Anika Therapeutics Navigates Geopolitical Risks Amid Global Conflicts

TipRanksNov 6 14:02

Anika Therapeutics | 10-Q: Q3 2024 Earnings Report

SECNov 5 05:44 · Announcements

Anika Therapeutics, Inc. (ANIK) Q3 2024 Earnings Call Transcript Summary

Futu NewsNov 3 10:08 · Conference Call

Anika Therapeutics Is Maintained at Outperform by Barrington Research

Dow JonesNov 1 23:23 · Ratings

Anika Therapeutics Analyst Ratings

BenzingaNov 1 23:12 · Ratings

Barrington Maintains Anika Therapeutics(ANIK.US) With Buy Rating, Cuts Target Price to $25

Futu NewsNov 1 22:31 · Ratings